Difference between revisions of "Clodronate (Bonefos)"
m (→Also known as) |
m |
||
| Line 1: | Line 1: | ||
| + | ''Not FDA approved; used in several other countries (Canada, Australia, the United Kingdom, Italy, others).'' | ||
| + | |||
==General information== | ==General information== | ||
Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.bayerresources.com.au/resources/uploads/PI/file9300.pdf Clodronate (Bonefos) package insert]</ref><ref>[[Media:Clodronate.pdf | Clodronate (Bonefos) package insert (locally hosted backup)]]</ref> | Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.<ref name="insert">[http://www.bayerresources.com.au/resources/uploads/PI/file9300.pdf Clodronate (Bonefos) package insert]</ref><ref>[[Media:Clodronate.pdf | Clodronate (Bonefos) package insert (locally hosted backup)]]</ref> | ||
| Line 15: | Line 17: | ||
==Patient drug information== | ==Patient drug information== | ||
*[http://www.uptodate.com/contents/clodronate-patient-drug-information Clodronate (Bonefos) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/clodronate-patient-drug-information Clodronate (Bonefos) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/clodronate-patient-drug-information Clodronate (Bonefos) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/clodronate-patient-drug-information Clodronate (Bonefos) patient drug information (UpToDate)]</ref> | ||
| − | |||
| − | |||
| − | |||
==Also known as== | ==Also known as== | ||
Revision as of 13:03, 8 May 2021
Not FDA approved; used in several other countries (Canada, Australia, the United Kingdom, Italy, others).
General information
Class/mechanism: Bisphosphonate, inhibits osteoclast activity, dissolution of hydroxyapatite crystals, and bone resorption/turnover.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Disease-specific information
For now this will be a gathering point for RCTs examining the use of this agent, which does not have clear antineoplastic properties; in the future this information may be moved to separate page(s).
Breast cancer
- Diel IJ, Solomayer EF, Costa SD, Gollan C, Goerner R, Wallwiener D, Kaufmann M, Bastert G. Reduction in new metastases in breast cancer with adjuvant clodronate treatment. N Engl J Med. 1998 Aug 6;339(6):357-63. link to original article PubMed
Multiple myeloma
- Lahtinen R, Laakso M, Palva I, Virkkunen P, Elomaa I. Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group. Lancet. 1992 Oct 31;340(8827):1049-52. Erratum in: Lancet 1992 Dec 5;340(8832):1420. link to original article PubMed
- MRC Myeloma IX: Morgan GJ, Davies FE, Gregory WM, Cocks K, Bell SE, Szubert AJ, Navarro-Coy N, Drayson MT, Owen RG, Feyler S, Ashcroft AJ, Ross F, Byrne J, Roddie H, Rudin C, Cook G, Jackson GH, Child JA; National Cancer Research Institute Haematological Oncology Clinical Study Group. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet. 2010 Dec 11;376(9757):1989-99. Epub 2010 Dec 3. link to original article link to PMC article PubMed
Patient drug information
Also known as
- Generic names: clodronate disodium, clodronic acid disodium tetrahydrate
- Brand names: Bonefos, Clasteon, Clastoban, Climaclod, Clodeosten, Clodran, Clodron, Clody, Difosfonal, Disdual, Lodronat, Loron, Lytos, Mebonat, Moticlod, Niklod, Ossiten, Ostac, Osteonorm, Osteostab, Sindronat